SCHEMBL11942294

SCHEMBL11942294

Cc1cc(C#N)nc(F)c1C

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 2/20 0.33
NQO1 P15559 1/20 0.33
GRM5 P41594 1/20 0.32
RECQL P46063 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16909271 0.80 KDM4E (0.39) CYP1A2CYP3A4CYP2C19KDM4EGRM5
SCHEMBL11986180 0.78 KDM4E (0.35) CYP1A2CYP3A4CYP2C19KDM4ENQO1
SCHEMBL11986179 0.75 KDM4E (0.33) KDM4ENQO1RECQLMEN1KMT2A
SCHEMBL11986177 0.75 ALDH1A1 (0.40) CYP1A2CYP2C19KDM4ERECQLMEN1
SCHEMBL11942295 0.75 CYP1A2 (0.35) CYP1A2CYP3A4CYP2C19KDM4ENQO1
SCHEMBL11986181 0.75 KDM4E (0.33) KDM4ENQO1RECQLMEN1KMT2A
SCHEMBL12641373 0.72 HTT (0.33) KDM4ERECQLMEN1KMT2A
SCHEMBL11942290 0.71 EGLN2 (0.39) CYP1A2CYP3A4CYP2C19NQO1GRM5
SCHEMBL8589238 0.70 KMT2A (0.30) KMT2A
SCHEMBL29441272 0.70 KMT2A (0.30) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452984-B2 Process for the preparation of 4-amino-3-chloro-5-fluoro-6-(substituted) picolinates DOW AGROSCIENCES LLC (US) 2016-09-27 US disclosed
US-20150274669-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-3-CHLORO-5-FLUORO-6-(SUBSTITUTED) PICOLINATES DOW AGROSCIENCES LLC (US) 2015-10-01 US disclosed
US-8993772-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2015-03-31 US disclosed
US-8993772-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2015-03-31 US disclosed
US-20140206881-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2014-07-24 US disclosed
US-20140206881-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2014-07-24 US disclosed
US-8754231-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2014-06-17 US disclosed
US-8754231-B2 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates DOW AGROSCIENCES, LLC. (US) 2014-06-17 US disclosed
US-20120190859-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES DOW AGROSCIENCES LLC (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274669-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-3-CHLORO-5-FLUORO-6-(SUBSTITUTED) PICOLINATES CYP4F3, AFF4, CYP4F12 CYP1A2 534/4885CYP3A4 12/4885CYP2C19 302/4885
US-20120190859-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES CYP4F3, CYP4F12, AFF4 CYP1A2 515/4885CYP3A4 13/4885CYP2C19 366/4885
US-20140206881-A1 PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-HALO-6-(SUBSTITUTED)PICOLINATES CYP4F3, CYP4F12, AFF4 CYP1A2 515/4885CYP3A4 13/4885CYP2C19 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.